| Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Common Stockholders |
The following table sets forth the computation of basic and diluted net income per share attributable to common stockholders (in thousands, except share and per share data): | | | | | | | | | | | | | Three Months Ended March 31, | | 2025 | | 2024 | | Basic EPS | | | | | Numerator: | | | | | Net income | $ | 576,419 | | | $ | 236,183 | | | Less: | | | | | Income attributable to options exercised by promissory notes | (144) | | | (726) | | | Income attributable to common stock subject to share repurchase agreements | — | | | (724) | | | Income attributable to unvested early exercised options | — | | | (1) | | | Net income attributable to common stockholders—Basic | $ | 576,275 | | | $ | 234,732 | | | Denominator: | | | | | Weighted-average shares used in computing net income per share—Basic | 339,837,238 | | | 335,794,739 | | | Net income per share attributable to common stockholders—Basic: | $ | 1.70 | | | $ | 0.70 | | | Diluted EPS | | | | | Numerator: | | | | | Net income | $ | 576,419 | | | $ | 236,183 | | | Less: | | | | | Income attributable to options exercised by promissory notes | (142) | | | (700) | | | Income attributable to common stock subject to share repurchase agreements | — | | | (698) | | | Income attributable to unvested early exercised options | — | | | (1) | | | Net income attributable to common stockholders—Diluted | $ | 576,277 | | | $ | 234,784 | | | Denominator: | | | | | Weighted-average shares used in computing net income per share—Basic | 339,837,238 | | | 335,794,739 | | | Weighted-average dilutive stock awards | 5,040,304 | | | 12,801,556 | | | Weighted-average shares used in computing net income per share—Diluted | 344,877,542 | | | 348,596,295 | | | Net income per share attributable to common stockholders—Diluted: | $ | 1.67 | | | $ | 0.67 | |
|
| Schedule of Antidilutive Potential Common Shares |
The following table presents the forms of antidilutive potential common shares: | | | | | | | | | | | | | As of March 31, | | 2025 | | 2024 | | Stock options exercised for promissory notes | 85,000 | | | 85,000 | | | Early exercised stock options | — | | | 559 | | | Stock options | — | | | 12,265 | | Unvested RSUs | 645 | | | 2,006,934 | | | ESPP | 31,203 | | | — | | | Total antidilutive potential common shares | 116,848 | | | 2,104,758 | |
|